Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial

Sheraz Yaqub, Morten Valberg, Bjørn Atle Bjørnbeth, Jon-Helge Angelsen, Kristoffer Watten Brudvik, Ina Andrassy Eilertsen, Richard Fristedt, Claus Wilki Fristrup, Stefan Gilg, Oskar Hemmingsson, Bengt Isaksson, Ingebjørg Soterud Juel, Anders Riegels Knudsen, Peter Nørgaard Larsen, Kim Erlend Mortensen, Inge Christoffer Olsen, Per Sandström, Oddvar Mathias Sandvik, Ernesto Sparrelid, Helena Taflin, Ragnhild A Lothe, Kjetil Taskén, Eline Aas, Hakon Blomstrand, Bergthor Björnsson, Jennie Engstrand, Åsmund Avdem Fretland, Jon Erik Grønbech, Merete Hektoen, Arild Horn, Visame Jonuzi, Dyre Kleive, Knut Jørgen Labori, Umair Majid, Linea Cecilie Melchior, Carlos Fernández Moro, Luís Nunes, Magnus Rizell, Bård Ingvald Røsok, Jon Arne Søreide, Anita Sveen, Olaug Villanger, Anne Waage

Open source

DOI: 10.1016/s2468-1253(26)00260-8
Published: 2026-09
Container: The Lancet Gastroenterology & Hepatology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-26-00260-8,
  title = {Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial},
  author = {Sheraz Yaqub and Morten Valberg and Bjørn Atle Bjørnbeth and Jon-Helge Angelsen and Kristoffer Watten Brudvik and Ina Andrassy Eilertsen and Richard Fristedt and Claus Wilki Fristrup and Stefan Gilg and Oskar Hemmingsson and Bengt Isaksson and Ingebjørg Soterud Juel and Anders Riegels Knudsen and Peter Nørgaard Larsen and Kim Erlend Mortensen and Inge Christoffer Olsen and Per Sandström and Oddvar Mathias Sandvik and Ernesto Sparrelid and Helena Taflin and Ragnhild A Lothe and Kjetil Taskén and Eline Aas and Hakon Blomstrand and Bergthor Björnsson and Jennie Engstrand and Åsmund Avdem Fretland and Jon Erik Grønbech and Merete Hektoen and Arild Horn and Visame Jonuzi and Dyre Kleive and Knut Jørgen Labori and Umair Majid and Linea Cecilie Melchior and Carlos Fernández Moro and Luís Nunes and Magnus Rizell and Bård Ingvald Røsok and Jon Arne Søreide and Anita Sveen and Olaug Villanger and Anne Waage},
  year = {2026},
  journal = {The Lancet Gastroenterology \&amp; Hepatology},
  doi = {10.1016/s2468-1253(26)00260-8},
  url = {https://doi.org/10.1016/s2468-1253(26)00260-8}
}

RIS

TY  - JOUR
TI  - Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial
AU  - Sheraz Yaqub
AU  - Morten Valberg
AU  - Bjørn Atle Bjørnbeth
AU  - Jon-Helge Angelsen
AU  - Kristoffer Watten Brudvik
AU  - Ina Andrassy Eilertsen
AU  - Richard Fristedt
AU  - Claus Wilki Fristrup
AU  - Stefan Gilg
AU  - Oskar Hemmingsson
AU  - Bengt Isaksson
AU  - Ingebjørg Soterud Juel
AU  - Anders Riegels Knudsen
AU  - Peter Nørgaard Larsen
AU  - Kim Erlend Mortensen
AU  - Inge Christoffer Olsen
AU  - Per Sandström
AU  - Oddvar Mathias Sandvik
AU  - Ernesto Sparrelid
AU  - Helena Taflin
AU  - Ragnhild A Lothe
AU  - Kjetil Taskén
AU  - Eline Aas
AU  - Hakon Blomstrand
AU  - Bergthor Björnsson
AU  - Jennie Engstrand
AU  - Åsmund Avdem Fretland
AU  - Jon Erik Grønbech
AU  - Merete Hektoen
AU  - Arild Horn
AU  - Visame Jonuzi
AU  - Dyre Kleive
AU  - Knut Jørgen Labori
AU  - Umair Majid
AU  - Linea Cecilie Melchior
AU  - Carlos Fernández Moro
AU  - Luís Nunes
AU  - Magnus Rizell
AU  - Bård Ingvald Røsok
AU  - Jon Arne Søreide
AU  - Anita Sveen
AU  - Olaug Villanger
AU  - Anne Waage
PY  - 2026
JO  - The Lancet Gastroenterology &amp; Hepatology
DO  - 10.1016/s2468-1253(26)00260-8
UR  - https://doi.org/10.1016/s2468-1253(26)00260-8
ER  -

APA

Yaqub, S., Valberg, M., Bjørnbeth, B. A., Angelsen, J., Brudvik, K. W., Eilertsen, I. A., Fristedt, R., Fristrup, C. W., Gilg, S., Hemmingsson, O., Isaksson, B., Juel, I. S., Knudsen, A. R., Larsen, P. N., Mortensen, K. E., Olsen, I. C., Sandström, P., Sandvik, O. M., Sparrelid, E., Taflin, H., Lothe, R. A., Taskén, K., Aas, E., Blomstrand, H., Björnsson, B., Engstrand, J., Fretland, Å. A., Grønbech, J. E., Hektoen, M., Horn, A., Jonuzi, V., Kleive, D., Labori, K. J., Majid, U., Melchior, L. C., Moro, C. F., Nunes, L., Rizell, M., Røsok, B. I., Søreide, J. A., Sveen, A., Villanger, O., & Waage, A. (2026). Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(26)00260-8

Source records

crossref · retrieved 2026-09-26T09:21:36.460Z